Shanthi Viswanathan

1.9k total citations · 1 hit paper
59 papers, 1.1k citations indexed

About

Shanthi Viswanathan is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Shanthi Viswanathan has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 24 papers in Pathology and Forensic Medicine and 13 papers in Rheumatology. Recurrent topics in Shanthi Viswanathan's work include Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (21 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Shanthi Viswanathan is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (21 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Shanthi Viswanathan collaborates with scholars based in Malaysia, United States and Singapore. Shanthi Viswanathan's co-authors include Ho Jin Kim, Sean J. Pittock, Kazuo Fujihara, Michael Levy, Dean M. Wingerchuk, N. А. Totolyan, Achim Berthele, Ichiro Nakashima, Murat Terzi and Amy Pace and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Shanthi Viswanathan

56 papers receiving 1.1k citations

Hit Papers

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica S... 2019 2026 2021 2023 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanthi Viswanathan Malaysia 14 622 596 206 198 96 59 1.1k
Élisabeth Maillart France 17 439 0.7× 693 1.2× 175 0.8× 139 0.7× 100 1.0× 100 1.0k
Sandrine Wiertlewski France 19 447 0.7× 740 1.2× 171 0.8× 428 2.2× 92 1.0× 48 1.2k
Becky Parks United States 17 348 0.6× 680 1.1× 167 0.8× 319 1.6× 94 1.0× 31 1.2k
Saif Huda United Kingdom 18 795 1.3× 382 0.6× 120 0.6× 86 0.4× 48 0.5× 56 1.0k
Edgar Carnero Contentti Argentina 17 465 0.7× 732 1.2× 214 1.0× 127 0.6× 82 0.9× 91 957
G. Akman‐Demir Türkiye 21 874 1.4× 360 0.6× 411 2.0× 103 0.5× 49 0.5× 34 1.7k
Jerome Graber United States 22 278 0.4× 259 0.4× 105 0.5× 155 0.8× 85 0.9× 71 1.4k
Fady Joseph United Kingdom 14 365 0.6× 474 0.8× 309 1.5× 124 0.6× 39 0.4× 23 1.0k
Ho Jin Kim South Korea 9 235 0.4× 543 0.9× 145 0.7× 442 2.2× 82 0.9× 13 960
Vuslat Yılmaz Türkiye 20 456 0.7× 116 0.2× 161 0.8× 241 1.2× 58 0.6× 72 1.1k

Countries citing papers authored by Shanthi Viswanathan

Since Specialization
Citations

This map shows the geographic impact of Shanthi Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanthi Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanthi Viswanathan more than expected).

Fields of papers citing papers by Shanthi Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanthi Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanthi Viswanathan. The network helps show where Shanthi Viswanathan may publish in the future.

Co-authorship network of co-authors of Shanthi Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Shanthi Viswanathan. A scholar is included among the top collaborators of Shanthi Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanthi Viswanathan. Shanthi Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feldman, David, Theodore Feldman, Brian Stein, et al.. (2025). Clinical and Engagement Results of a Nationwide Comprehensive Remote Patient Care Hypertension Program. JACC Advances. 4(7). 101892–101892.
2.
Siritho, Sasitorn, Shanthi Viswanathan, Fu Liong Hiew, et al.. (2023). Facilities, selection, outcome measurement, and limitations of therapeutic plasma exchange for neuroimmunological disorders: The South East Asian survey study. Journal of Clinical Apheresis. 38(4). 437–446. 1 indexed citations
3.
Solomon, Andrew, Ruth Ann Marrie, Shanthi Viswanathan, et al.. (2023). Global Barriers to the Diagnosis of Multiple Sclerosis. Neurology. 101(6). e624–e635. 29 indexed citations
4.
Chew, Elaine, et al.. (2023). Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study. Multiple Sclerosis and Related Disorders. 79. 104992–104992. 2 indexed citations
5.
Lim, Jia Lun, Shen‐Yang Lim, Ai Huey Tan, et al.. (2021). Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson’s disease in patients of Malay ancestry. Neurological Sciences. 42(10). 4203–4207. 3 indexed citations
7.
10.
Hiew, Fu Liong, et al.. (2018). Anti-NMDAR encephalitis in association with herpes simplex virus and viral and bacterial zoonoses. Annals of Indian Academy of Neurology. 22(1). 102–102. 2 indexed citations
11.
Hiew, Fu Liong, et al.. (2018). Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years. Journal of Clinical Neuroscience. 50. 203–207. 4 indexed citations
12.
Viswanathan, Shanthi, et al.. (2018). Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups. Multiple Sclerosis and Related Disorders. 25. 300–308. 11 indexed citations
13.
Hiew, Fu Liong, et al.. (2017). Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria. Clinical Neurology and Neurosurgery. 158. 114–118. 29 indexed citations
14.
Viswanathan, Shanthi, et al.. (2017). A curious case of neuromyelitis optica spectrum disorder co-existing with idiopathic intracranial hypertension. Journal of Clinical Neuroscience. 41. 104–106. 2 indexed citations
15.
Ahmad‐Annuar, Azlina, Huihua Li, Yi Zhao, et al.. (2016). PARK16 is associated with PD in the Malaysian population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(6). 839–847. 13 indexed citations
16.
Viswanathan, Shanthi, et al.. (2016). Acute disseminated encephalomyelitis complicating dengue infection with neuroimaging mimicking multiple sclerosis: A report of two cases. Multiple Sclerosis and Related Disorders. 10. 112–115. 10 indexed citations
17.
Viswanathan, Shanthi, Hiu Yi Wong, Amy May Lin Quek, & Nobuhiro Yuki. (2015). Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica. Journal of Neuroimmunology. 282. 92–96. 35 indexed citations
18.
Viswanathan, Shanthi, et al.. (2013). Virilizing ovarian Leydig cell tumour. The Journal of Clinical and Scientific Research. 101–104. 1 indexed citations
19.
Viswanathan, Shanthi, et al.. (2012). Pneumonitis following diesel fuel siphonage. Respiratory Medicine Case Reports. 5. 9–11. 3 indexed citations
20.
Viswanathan, Shanthi, et al.. (2008). Osteochondroma-like parosteal osteosarcoma. Indian Journal of Pathology and Microbiology. 51(1). 58–58. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026